These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20063521)

  • 1. Cancer stem cell immunotherapy: the right bullet for the right target.
    Ghebeh H; Bakr MM; Dermime S
    Hematol Oncol Stem Cell Ther; 2008; 1(1):1-2. PubMed ID: 20063521
    [No Abstract]   [Full Text] [Related]  

  • 2. Current vaccine trials in glioblastoma: a review.
    Xu LW; Chow KK; Lim M; Li G
    J Immunol Res; 2014; 2014():796856. PubMed ID: 24804271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell vaccines to combat glioblastoma.
    Wheeler CJ
    Expert Rev Neurother; 2010 Apr; 10(4):483-6. PubMed ID: 20367199
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary report on tumor stem cell/B cell hybridoma vaccine for recurrent glioblastoma multiforme.
    Moviglia GA; Carrizo AG; Varela G; Gaeta CA; Paes de Lima A; Farina P; Molina H
    Hematol Oncol Stem Cell Ther; 2008; 1(1):3-13. PubMed ID: 20063522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy trials for glioblastoma multiforme: promise and pitfalls.
    Yong RL; Lonser RR
    World Neurosurg; 2012; 77(5-6):636-8. PubMed ID: 22120230
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain tumor stem cells: new targets for clinical treatments?
    Tunici P; Irvin D; Liu G; Yuan X; Zhaohui Z; Ng H; Yu JS
    Neurosurg Focus; 2006 Apr; 20(4):E27. PubMed ID: 16709033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-Based Immunotherapeutics for the Treatment of Glioblastoma: Advances, Challenges, and Future Perspectives.
    Cuoco JA; Benko MJ; Busch CM; Rogers CM; Prickett JT; Marvin EA
    World Neurosurg; 2018 Dec; 120():302-315. PubMed ID: 30196171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hope and challenges for dendritic cell-based vaccine therapy for glioblastoma.
    Nakano I; Chiocca EA
    World Neurosurg; 2012; 77(5-6):633-5. PubMed ID: 22120228
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy in human glioblastoma.
    Szabo AT; Carpentier AF
    Rev Neurol (Paris); 2011 Oct; 167(10):668-72. PubMed ID: 21885075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation vaccines are showing promise against glioblastoma.
    Dillman RO; Bota DA
    Oncotarget; 2024 Aug; 15():543-548. PubMed ID: 39102214
    [No Abstract]   [Full Text] [Related]  

  • 11. Dendritic cell immunotherapy for glioblastoma.
    Polyzoidis S; Ashkan K
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):761-3. PubMed ID: 24850137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agenus cancer vaccine extends survival of GBM patients.
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(2):252-3. PubMed ID: 24963517
    [No Abstract]   [Full Text] [Related]  

  • 13. An Innovative Immunotherapy Vaccine with Combination Checkpoint Blockade as a First Line Treatment for Glioblastoma in the Context of Current Treatments.
    Coxon AT; Johanns TM; Dunn GP
    Mo Med; 2020; 117(1):45-49. PubMed ID: 32158049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approaches and mechanisms of immunotherapy for glioblastoma.
    Hegde M; Bielamowicz KJ; Ahmed N
    Discov Med; 2014 Mar; 17(93):145-54. PubMed ID: 24641957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in active-specific immunotherapy of brain malignancies.
    Tjoa BA; Salgaller ML
    Expert Opin Investig Drugs; 2000 Sep; 9(9):2093-101. PubMed ID: 11060795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What's next in glioblastoma treatment: Tumor-targeted or immune-targeted therapies?].
    Schernberg A; Marabelle A; Massard C; Armand JP; Dumont S; Deutsch E; Dhermain F
    Bull Cancer; 2016 May; 103(5):484-98. PubMed ID: 27032303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma Patients.
    Nava S; Lisini D; Pogliani S; Dossena M; Bersano A; Pellegatta S; Parati E; Finocchiaro G; Frigerio S
    Stem Cells Transl Med; 2015 Oct; 4(10):1164-72. PubMed ID: 26273063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of autologous cancer cell vaccination and cellular immunotherapy using anti-CD3 stimulated lymphocytes in patients with recurrent grade III/IV astrocytoma.
    Wood GW; Holladay FP; Turner T; Wang YY; Chiga M
    J Neurooncol; 2000 Jun; 48(2):113-20. PubMed ID: 11083074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising vaccines for treating glioblastoma.
    Swartz AM; Shen SH; Salgado MA; Congdon KL; Sanchez-Perez L
    Expert Opin Biol Ther; 2018 Nov; 18(11):1159-1170. PubMed ID: 30281978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives for immunotherapy in glioblastoma treatment.
    Finocchiaro G; Pellegatta S
    Curr Opin Oncol; 2014 Nov; 26(6):608-14. PubMed ID: 25210870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.